Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Dane Wittrup

Showing results (1-10 of 175) with videos related to

Pageof 18
Sort By:
Trends in Cancer|September 5, 2017
Antitumor Antibodies Can Drive Therapeutic T Cell ResponsesK Dane Wittrup
Immunological Reviews|July 6, 2023
Spatiotemporally programming cytokine immunotherapies through protein engineeringLuciano Santollani, K Dane Wittrup
Biotechnology and Bioengineering|December 8, 2005
Contrasting secretory processing of simultaneously expressed heterologous proteins in Saccharomyces cerevisiaeAndy Rakestraw, K Dane Wittrup
Methods in Enzymology|January 11, 2012
Protein engineering for therapeutics, part B. PrefaceK Dane Wittrup, Gregory L Verdine
Protein Science : a Publication of the Protein Society|January 26, 2006
Context-dependent mutations predominate in an engineered high-affinity single chain antibody fragmentKatarina S Midelfort, K Dane Wittrup
Molecular Cancer Therapeutics|October 15, 2009
A modeling analysis of the effects of molecular size and binding affinity on tumor targetingMichael M Schmidt, K Dane Wittrup
Biotechnology Progress|April 6, 2002
Quantitative screening of yeast surface-displayed polypeptide libraries by magnetic bead captureYik A Yeung, K Dane Wittrup
Cancer Research|March 22, 2003
Theoretical analysis of antibody targeting of tumor spheroids: importance of dosage for penetration, and affinity for retentionChristilyn P Graff, K Dane Wittrup
Methods in Enzymology|January 3, 2012
Protein engineering for therapeutics, Part A. PrefaceK Dane Wittrup, Gregory L Verdine
Trends in Immunology|December 15, 2018
What, Why, Where, and When: Bringing Timing to Immuno-OncologyAdrienne M Rothschilds, K Dane Wittrup
Pageof 18

Showing results (1-10 of 175) with videos related to

Sort By:
Pageof 18
Trends in Cancer|September 5, 2017
Antitumor Antibodies Can Drive Therapeutic T Cell ResponsesK Dane Wittrup
Immunological Reviews|July 6, 2023
Spatiotemporally programming cytokine immunotherapies through protein engineeringLuciano Santollani, K Dane Wittrup
Biotechnology and Bioengineering|December 8, 2005
Contrasting secretory processing of simultaneously expressed heterologous proteins in Saccharomyces cerevisiaeAndy Rakestraw, K Dane Wittrup
Methods in Enzymology|January 11, 2012
Protein engineering for therapeutics, part B. PrefaceK Dane Wittrup, Gregory L Verdine
Protein Science : a Publication of the Protein Society|January 26, 2006
Context-dependent mutations predominate in an engineered high-affinity single chain antibody fragmentKatarina S Midelfort, K Dane Wittrup
Molecular Cancer Therapeutics|October 15, 2009
A modeling analysis of the effects of molecular size and binding affinity on tumor targetingMichael M Schmidt, K Dane Wittrup
Biotechnology Progress|April 6, 2002
Quantitative screening of yeast surface-displayed polypeptide libraries by magnetic bead captureYik A Yeung, K Dane Wittrup
Cancer Research|March 22, 2003
Theoretical analysis of antibody targeting of tumor spheroids: importance of dosage for penetration, and affinity for retentionChristilyn P Graff, K Dane Wittrup
Methods in Enzymology|January 3, 2012
Protein engineering for therapeutics, Part A. PrefaceK Dane Wittrup, Gregory L Verdine
Trends in Immunology|December 15, 2018
What, Why, Where, and When: Bringing Timing to Immuno-OncologyAdrienne M Rothschilds, K Dane Wittrup
Pageof 18